Forte Biosciences Inc (FBRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -28,323 | -19,931 | -7,420 | -31,476 | -25,604 |
| Depreciation Amortization | 27 | 8 | 9 | 9 | -136 |
| Accounts payable and accrued liabilities | 3,735 | 3,851 | 261 | 271 | 4,137 |
| Other Working Capital | 5,162 | 5,713 | -55 | -392 | 3,499 |
| Other Operating Activity | -1,337 | -2,244 | 538 | 2,882 | -1,633 |
| Operating Cash Flow | $-20,736 | $-12,603 | $-6,667 | $-28,706 | $-19,737 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | N/A | 135 | 134 |
| PPE Investments | -6 | -6 | -6 | -88 | -71 |
| Investing Cash Flow | $-6 | $-6 | $-6 | $47 | $63 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 14 | 8 | 8 | 25,016 | 24,807 |
| Other Financing Activity | -34 | -26 | -16 | -332 | -48 |
| Financing Cash Flow | $-20 | $-18 | $-8 | $24,684 | $24,759 |
| Beginning Cash Position | 37,125 | 37,125 | 37,125 | 41,100 | 41,100 |
| End Cash Position | 16,363 | 24,498 | 30,444 | 37,125 | 46,185 |
| Net Cash Flow | $-20,762 | $-12,627 | $-6,681 | $-3,975 | $5,085 |
| Free Cash Flow | |||||
| Operating Cash Flow | -20,736 | -12,603 | -6,667 | -28,706 | -19,737 |
| Capital Expenditure | -6 | -6 | -6 | -88 | -71 |
| Free Cash Flow | -20,742 | -12,609 | -6,673 | -28,794 | -19,808 |